In line with this, an article first reported in 2019 that aneuploid CTECs, like CTCs, can also express a series of tumor markers, such as HER2, PD‐L1, EpCAM, and the stem cell marker CD44.38 The gene discussed is EPCAM; the disease is neoplasm.